India to Netherlands: Rosuvastatin Export Trade Route
India has recorded 973 verified shipments of Rosuvastatin exported to Netherlands, representing a combined trade value of $21.9M USD. This corridor is served by 11 active Indian exporters, with an average shipment value of $22.5K USD. The leading Indian exporter is MEDREICH LIMITED, which accounts for 45% of total export value with 313 shipments worth $9.8M USD. On the buying side, BGP PRODUCTS GMBH is the largest importer in Netherlands with $11.9M USD in purchases. The top 3 suppliers — MEDREICH LIMITED, UNISON PHARMACEUTICALS PRIVATE LIMITED, MEDREICH LIMITED — together control 76% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Netherlands Rosuvastatin corridor is one of India's established pharmaceutical export routes, with 973 shipments documented worth a combined $21.9M USD. The route is dominated by MEDREICH LIMITED, which alone accounts for roughly 45% of all export value, reflecting the consolidated nature of India's rosuvastatin manufacturing sector.
Across 11 active suppliers, the average shipment value stands at $22.5K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 70% of all shipments, consistent with rosuvastatin's non-urgent bulk-order profile.
Shipment activity peaks during April-June, with an average transit time of 20 days port-to-port. The route has recorded an annual growth rate of 5%, placing it at rank #5 among India's top rosuvastatin export destinations globally.
On the import side, key buyers of Indian rosuvastatin in Netherlands include BGP PRODUCTS GMBH, BGP Products GmbH, BGP PRODUCTS GMBH and 52 others. BGP PRODUCTS GMBH is the single largest importer with 452 shipments valued at $11.9M USD.
